Company intelligence / Profile preview

CTI Life Sciences Fund

Montreal, Quebec, Canadactisciences.com ↗

Ownership: Private
Employees: ~5
Development stage: Other

Overview

CTI Life Sciences Fund is a Montreal-based venture capital firm established in 2006 that specializes in investments in innovative life sciences and biotechnology companies at pre-clinical and clinical development stages. It manages over $345–$375 million across multiple funds and has supported more than twenty successful investments with several exits and FDA approvals. Its investment focus spans Canada primarily but also includes select opportunities in the U.S. and Europe.

Industry: Investors

Partnerships

Vernalis (licensing agreement)

Beyond the preview

Go deeper on CTI Life Sciences Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTI Life Sciences Fund.

Explore the full profile